QQ客服 官方微博 反馈留言

浏览/检索结果: 共5条，第1-5条 帮助 限定条件 专题：中国医学科学院 北京协和医学院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Solid Fuel Use and Risks of Respiratory Diseases A Cohort Study of 280,000 Chinese Never-Smokers 期刊论文 2019, 卷号: 199, 期号: 3, 页码: 352-361 作者:  Chan, Ka Hung;  Kurmi, Om P.;  Bennett, Derrick A.;  Yang, Ling;  Chen, Yiping 收藏  |  浏览/下载：109/0  |  提交时间：2020/01/03 solid fuels  chronic obstructive pulmonary disease  acute lower respiratory infection  household air pollution   Does utilizing WHO's interim targets further reduce the risk - meta-analysis on ambient particulate matter pollution and mortality of cardiovascular diseases? 期刊论文 2018, 卷号: 242, 期号: Pt B, 页码: 1299-1307 作者:  Liu, Zhiguang;  Wang, Feng;  Li, Wentao;  Yin, Lu;  Wang, Yuebo 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03 Meta-analysis  Particulate matter  Cohort studies  Mortality  Cardiovascular diseases   DOES UTILIZINGE WHO INTERIM TARGETS FURTHER REDUCE THE RISK - META-ANALYSIS ON AMBIENT PARTICULATE MATTER POLLUTION AND MORTALITY OF CARDIOVASCULAR DISEASES? 期刊论文 2018, 卷号: 36, 页码: E308-E308 作者:  Liu, Zhiguang;  Wang, Feng;  Li, Wentao;  Yin, Lu;  Yan, Ruohua 收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03 Meta-analysis  Particulate matter  Cohort studies  Mortality  Cardiovascular diseases   DOES UTILIZINGE WHO INTERIM TARGETS FURTHER REDUCE THE RISK - META-ANALYSIS ON AMBIENT PARTICULATE MATTER POLLUTION AND MORTALITY OF CARDIOVASCULAR DISEASES? 会议论文 JOURNAL OF HYPERTENSION, 2018-10-01 作者:  Liu, Zhiguang;  Wang, Feng;  Li, Wentao;  Yin, Lu;  Yan, Ruohua 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03 Meta-analysis  Particulate matter  Cohort studies  Mortality  Cardiovascular diseases   Efficacy and safety of pemetrexed/cisplatin versus gemcitabine/cisplatin as first-line treatment in Chinese patients with advanced nonsquamous non-small cell lung cancer 期刊论文 2014, 卷号: 85, 期号: 3, 页码: 401-7 作者:  Wu Yi-Long;  Lu Shun;  Cheng Ying;  Zhou Caicun;  Wang Mengzhao 收藏  |  浏览/下载：8/0  |  提交时间：2020/01/13 Chinese  Cisplatin  First-line chemotherapy  Gemcitabine  Non-small cell lung cancer  Nonsquamous  Pemetrexed